Peptide research profile
BPC-157
Also known as Body Protection Compound-157 · gastric pentadecapeptide BPC-157
There is no adequate randomized human evidence establishing recovery, musculoskeletal, or gastrointestinal benefit. Popularity and preclinical signals should not be mistaken for proven clinical outcomes.
Very low evidenceNot FDA approved
- Evidence maturity
- Early signal
- Regulatory status
- Not FDA approved
- Recorded outcomes
- 3
- Indexed sources
- 2
- Side-effect records
- 19Named most often: Anhedonia
Educational. Not medical advice.
Summary
An unapproved experimental peptide supported mainly by cell and animal injury models.
What is BPC-157 being studied for?
Musculoskeletal and gastrointestinal research
How is it thought to work?
Human mechanism is unestablished. Proposed nitric-oxide, angiogenesis, vascular, and tissue-repair pathways come largely from preclinical work.
Recorded outcomes
19 side-effect records on BPC-157
Free account3 graded outcomes and 2 sources for BPC-157.
Outcome table and every source open with a free account. No card.
Update history
Updated
- Editorial review of the profile and its sources.
- Record last updated in the Senzu database.
- Profile first published.